Vše

Co hledáte?

Vše
Projekty
Výsledky výzkumu
Subjekty

Rychlé hledání

  • Projekty podpořené TA ČR
  • Významné projekty
  • Projekty s nejvyšší státní podporou
  • Aktuálně běžící projekty

Chytré vyhledávání

  • Takto najdu konkrétní +slovo
  • Takto z výsledků -slovo zcela vynechám
  • “Takto můžu najít celou frázi”

Simple new method for labelling of PSMA-11 with Ga-68 in NaHCO3

Identifikátory výsledku

  • Kód výsledku v IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F61389005%3A_____%2F21%3A00542585" target="_blank" >RIV/61389005:_____/21:00542585 - isvavai.cz</a>

  • Nalezeny alternativní kódy

    RIV/68407700:21340/21:00350211

  • Výsledek na webu

    <a href="https://doi.org/10.1016/j.apradiso.2021.109692" target="_blank" >https://doi.org/10.1016/j.apradiso.2021.109692</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1016/j.apradiso.2021.109692" target="_blank" >10.1016/j.apradiso.2021.109692</a>

Alternativní jazyky

  • Jazyk výsledku

    angličtina

  • Název v původním jazyce

    Simple new method for labelling of PSMA-11 with Ga-68 in NaHCO3

  • Popis výsledku v původním jazyce

    Background: Prostate specific membrane antigen (PSMA) is a type II membrane protein widely expressed on the surface of prostate cancer cells. One of its functions is to act as a receptor mediating the ligand internalization. This PSMA property is employed in the diagnostics and therapy of prostate cancer.nOver the years, small molecules with high affinity for PSMA have been developed and labelled with positron emitters (e.g. Ga-68, F-18, C-11, Cu-64, or Y-86). One of these radiolabelled ligands, [Ga-68] PSMA-11, is one of the most widespread tracers for PET imaging of the prostate cancer.nMany techniques have been proposed and tested for the Ga-68 labelling of PSMA-11. The aim of our work was to design a labelling method of PSMA-11 that minimizes number of the used chemicals and steps, providing quantitative labelling yield at laboratory temperature and may be easily automated.nMethodology: A Ge-68/Ga-68 generator eluate in 0.1 M HCl was loaded on an activated Oasis MCX cartridge, and the cartridge was then thoroughly washed with water. The radionuclide Ga-68 was eluted from the cartridge with 0.1 M NaHCO3 (pH = 8.5, n = 36) or with the same solution with pH adjusted to 7.2-9.0 (n = 38). Precursor PSMA11 was mixed directly with the cartridge eluate of Ga-68 in 0.1 M NaHCO3 of given pH.nFor the stability test, samples of (68)GaPSMA-11 in 0.1 M NaHCO3 (pH 8.5) were mixed in ratio 1 : 1 with the following solutions: 0.1 M NaHCO3 (pH 8.5), human serum, PBS and 0.9% NaCl.nIn order to estimate an effect of the time elapsed between Ga-68 elution from the cartridge in 0.1 M NaHCO3 (pH 8.5) and the labelling onset of PSMA-11, the latter was initiated 0, 5, 10 and 20 min post elution and radio-chemical yield was monitored.nAll the PSMA-11 labelled samples were subjected to radiochemical purity test using HPLC. The whole process starting from generator elution up to HPLC analysis commencement took 10-15 min.nResults: Recovery of Ga-68 from cartridge Oasis MCX using 0.1 M NaHCO3 at pH 8.5 was 71.5 +/- 1.4%. Thirty six PSMA-11 samples (10 mu g in reaction mixture) were labelled at pH 8.5 with total average radiochemical yield of 98 +/- 2%.nRecovery of Ga-68 from cartridge Oasis MCX using 0.1 M NaHCO3 at variable pH of 7.2-9.0 was 62.5 +/- 1.8% showing certain decrease with decreasing pH. A total of 138 samples of PSMA-11 were labelled with Ga-68 at variable pH (7.2-9.0) and four different amounts of PSMA-11 (1, 2.5, 5 and 10 mu g) resulting in the labelling yields of 54.0 +/- 5.3%, 88.2 +/- 3.2%, 99.4 +/- 0.3% and 99.9 +/- 0.1%, respectively. Irrespective of the pH, the radiolabelling yield was quantitative for the molar ratio PSMA-11: Ga-68 > 5000 : 1 in the reaction mixture.nStability tests in 0.1 M NaHCO3 (pH 8.5), human serum, PBS and 0.9% NaCl revealed no observable release of Ga-68 from the Ga-68-PSMA-11 complex within 3 h. Similarly, the delay between the Ga-68 elution from the Oasis MCX cartridge in 0.1 M NaHCO3 (pH 8.5) and start of the labelling of PSMA-11 labelling has no effect on the radiochemical yield.nConclusion: A new method of labelling PSMA-11 ligand with Ga-68 in 0.1 M NaHCO3 using Oasis MCX cartridges was proposed, developed and tested. The results demonstrated that it is rapid, simple, reproducible and easy to automate.

  • Název v anglickém jazyce

    Simple new method for labelling of PSMA-11 with Ga-68 in NaHCO3

  • Popis výsledku anglicky

    Background: Prostate specific membrane antigen (PSMA) is a type II membrane protein widely expressed on the surface of prostate cancer cells. One of its functions is to act as a receptor mediating the ligand internalization. This PSMA property is employed in the diagnostics and therapy of prostate cancer.nOver the years, small molecules with high affinity for PSMA have been developed and labelled with positron emitters (e.g. Ga-68, F-18, C-11, Cu-64, or Y-86). One of these radiolabelled ligands, [Ga-68] PSMA-11, is one of the most widespread tracers for PET imaging of the prostate cancer.nMany techniques have been proposed and tested for the Ga-68 labelling of PSMA-11. The aim of our work was to design a labelling method of PSMA-11 that minimizes number of the used chemicals and steps, providing quantitative labelling yield at laboratory temperature and may be easily automated.nMethodology: A Ge-68/Ga-68 generator eluate in 0.1 M HCl was loaded on an activated Oasis MCX cartridge, and the cartridge was then thoroughly washed with water. The radionuclide Ga-68 was eluted from the cartridge with 0.1 M NaHCO3 (pH = 8.5, n = 36) or with the same solution with pH adjusted to 7.2-9.0 (n = 38). Precursor PSMA11 was mixed directly with the cartridge eluate of Ga-68 in 0.1 M NaHCO3 of given pH.nFor the stability test, samples of (68)GaPSMA-11 in 0.1 M NaHCO3 (pH 8.5) were mixed in ratio 1 : 1 with the following solutions: 0.1 M NaHCO3 (pH 8.5), human serum, PBS and 0.9% NaCl.nIn order to estimate an effect of the time elapsed between Ga-68 elution from the cartridge in 0.1 M NaHCO3 (pH 8.5) and the labelling onset of PSMA-11, the latter was initiated 0, 5, 10 and 20 min post elution and radio-chemical yield was monitored.nAll the PSMA-11 labelled samples were subjected to radiochemical purity test using HPLC. The whole process starting from generator elution up to HPLC analysis commencement took 10-15 min.nResults: Recovery of Ga-68 from cartridge Oasis MCX using 0.1 M NaHCO3 at pH 8.5 was 71.5 +/- 1.4%. Thirty six PSMA-11 samples (10 mu g in reaction mixture) were labelled at pH 8.5 with total average radiochemical yield of 98 +/- 2%.nRecovery of Ga-68 from cartridge Oasis MCX using 0.1 M NaHCO3 at variable pH of 7.2-9.0 was 62.5 +/- 1.8% showing certain decrease with decreasing pH. A total of 138 samples of PSMA-11 were labelled with Ga-68 at variable pH (7.2-9.0) and four different amounts of PSMA-11 (1, 2.5, 5 and 10 mu g) resulting in the labelling yields of 54.0 +/- 5.3%, 88.2 +/- 3.2%, 99.4 +/- 0.3% and 99.9 +/- 0.1%, respectively. Irrespective of the pH, the radiolabelling yield was quantitative for the molar ratio PSMA-11: Ga-68 > 5000 : 1 in the reaction mixture.nStability tests in 0.1 M NaHCO3 (pH 8.5), human serum, PBS and 0.9% NaCl revealed no observable release of Ga-68 from the Ga-68-PSMA-11 complex within 3 h. Similarly, the delay between the Ga-68 elution from the Oasis MCX cartridge in 0.1 M NaHCO3 (pH 8.5) and start of the labelling of PSMA-11 labelling has no effect on the radiochemical yield.nConclusion: A new method of labelling PSMA-11 ligand with Ga-68 in 0.1 M NaHCO3 using Oasis MCX cartridges was proposed, developed and tested. The results demonstrated that it is rapid, simple, reproducible and easy to automate.

Klasifikace

  • Druh

    J<sub>imp</sub> - Článek v periodiku v databázi Web of Science

  • CEP obor

  • OECD FORD obor

    30224 - Radiology, nuclear medicine and medical imaging

Návaznosti výsledku

  • Projekt

    Výsledek vznikl pri realizaci vícero projektů. Více informací v záložce Projekty.

  • Návaznosti

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Ostatní

  • Rok uplatnění

    2021

  • Kód důvěrnosti údajů

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Údaje specifické pro druh výsledku

  • Název periodika

    Applied Radiation and Isotopes

  • ISSN

    0969-8043

  • e-ISSN

  • Svazek periodika

    172

  • Číslo periodika v rámci svazku

    JUN

  • Stát vydavatele periodika

    GB - Spojené království Velké Británie a Severního Irska

  • Počet stran výsledku

    9

  • Strana od-do

    109692

  • Kód UT WoS článku

    000640178800030

  • EID výsledku v databázi Scopus

    2-s2.0-85102860691